Functional Annotation Report: Yeast SSB1 (P11484 / YDL229W)

UniProt: P11484 · Gene: SSB1 (synonym YG101; ORF YDL229W) · Organism: Saccharomyces cerevisiae (S288c)
Family: Heat-shock protein 70 (Hsp70), Ssb-type · EC: 3.6.4.10 (ATP-driven chaperone)

Summary

SSB1 (systematic name YDL229W, UniProt P11484) of Saccharomyces cerevisiae (strain S288c) encodes Ssb1, a cytosolic, ATP-dependent molecular chaperone of the heat shock protein 70 (Hsp70) family, belonging specifically to the Ssb-type subfamily. Its primary, defining function is co-translational protein folding: Ssb1 is physically tethered to the large (60S) ribosomal subunit near the polypeptide exit tunnel, where it captures emerging nascent polypeptide chains and, through cycles of ATP-driven binding and release, prevents their premature misfolding and aggregation until they can attain a folding-competent or native state. Its catalytic activity is that of an ATPase — EC 3.6.4.10, ATP + H₂O → ADP + phosphate + H⁺ — and this ATPase cycle is the engine that powers substrate binding and release. Importantly, this yeast Hsp70 chaperone is entirely unrelated to the identically-named human single-stranded-DNA-binding proteins (SSB/SSB1); the gene symbol here refers unambiguously to a ribosome-associated Hsp70 in baker's yeast, and the protein family, domains (ATPase_NBD, Hsp70 peptide-binding domain), and organism all align with this identity.

Ssb1 does not act alone. Its ATPase activity is stimulated by the ribosome-associated complex (RAC), a stable heterodimer of the J-domain co-chaperone Zuo1 and the atypical Hsp70 Ssz1, which functions as the specialized J-protein cochaperone that activates Ssb on the ribosome. The nucleotide-exchange step of the cycle — the release of ADP to reset the chaperone for another round — is supplied by the Hsp110 protein Sse1. Together this forms a complete, mechanistically-defined Hsp70 reaction cycle operating directly at the ribosomal exit site. Ssb1 selectively engages short, degenerate sequence motifs enriched in positively charged and aromatic residues, and for a defined class of clients — notably WD40 β-propeller proteins — it acts as the upstream relay that hands substrates to the chaperonin TRiC/CCT.

Beyond folding of the nascent proteome, Ssb1 contributes to translational fidelity, translation termination, and ribosome biogenesis; it suppresses de novo [PSI⁺] prion formation by correctly folding nascent Sup35; and it carries out a distinct extra-ribosomal signaling role, bridging the SNF1/AMPK–Glc7 phosphatase axis together with the 14-3-3 protein Bmh1 to regulate glucose repression. Ssb1 has a nearly identical paralog, Ssb2 (P40150), with which it shares 99.3% sequence identity (differing at only 4 of 613 residues), explaining their broad functional redundancy — the two are usually treated together as "Ssb1/2."

Key Findings

1. Ssb1 is a ribosome-associated Hsp70 that binds nascent chains to assist co-translational folding

The central function of Ssb1 is to bind newly synthesized polypeptides as they emerge from the translating ribosome and to keep them folding-competent. In vivo selective ribosome profiling has mapped Ssb–nascent-chain interactions at near-residue resolution and revealed the principle of substrate recognition: Ssb "engages most substrates by multiple binding-release cycles to a degenerate sequence enriched in positively charged and aromatic amino acids" (PMID: 28708998). This defines the substrate specificity of Ssb — it is not sequence-specific in a strict sense but recognizes a physicochemical signature (basic and aromatic residues) that is common in unfolded regions of nascent chains.

The functional consequence of this activity is demonstrated by loss-of-function studies: deletion of SSB "leads to widespread aggregation of newly synthesized polypeptides" (PMID: 23332755). This establishes that Ssb is essential for maintaining the solubility and folding competence of the nascent proteome — without it, freshly translated proteins misfold and aggregate on a genome-wide scale. Ssb is therefore best described as a general co-translational holdase/foldase operating at the front line of protein biogenesis.

2. Ssb ATPase activity is stimulated by the ribosome-associated complex (RAC = Zuo1 + Ssz1)

Like all Hsp70 chaperones, Ssb requires a J-domain (Hsp40-type) co-chaperone to stimulate its otherwise weak intrinsic ATPase activity and thereby drive high-affinity substrate capture. For Ssb, this role is played by the RAC heterodimer — a complex of the J-protein Zuo1 and the non-canonical Hsp70 Ssz1. RAC "stimulates the ATPase activity of the ribosome-bound Hsp70 homolog Ssb, which interacts with nascent polypeptide chains to facilitate de novo protein folding" (PMID: 28771464).

Crosslinking experiments confirm that this stimulation is functionally required for substrate engagement: "an efficient crosslink of the nascent chain to Ssb1/2p depends on the presence of functional RAC," including a functional Zuo1 J-domain (PMID: 11929994). This establishes RAC as the obligate activating co-chaperone that couples Ssb's ATPase cycle to productive nascent-chain binding, forming what has been described as a "functional chaperone triad" (Ssb + Zuo1 + Ssz1) on the yeast ribosome.

3. Ssb binds the ribosomal tunnel exit via uL23/Rpl25, positioning its substrate-binding domain to receive nascent chains

The spatial organization of Ssb on the ribosome has been resolved structurally. Cryo-EM structures of ribosome-bound yeast Ssb identify Rpl25/uL23 as the ribosomal binding site and reveal the chaperone's interaction with a model nascent chain (PMID: 41545346). uL23 is the universal docking hub at the exit tunnel used by many ribosome-associated factors, and its identification pinpoints exactly where Ssb sits.

Critically, the structures show that RAC "positions the substrate binding domain of Ssb-ATP close to the tunnel exit to receive nascent chains" (PMID: 41545346). This provides a mechanistic picture: RAC not only chemically activates Ssb's ATPase but also geometrically orients the ATP-bound (open, low-affinity) form of Ssb's substrate-binding domain (SBD) directly over the tunnel exit, so that emerging chains are captured the moment they appear. Upon ATP hydrolysis, Ssb undergoes conformational changes to the closed (high-affinity) state while remaining anchored by the bound nascent chain — completing the capture step of the cycle at the correct location.

4. RAC/Ssb maintains translational fidelity, termination, and ribosome biogenesis

The RAC/Ssb system's influence extends to the accuracy of translation itself. Loss of RAC or Ssb1/2p impairs translational fidelity — producing defects in termination and amino-acid misincorporation — and confers hypersensitivity to the aminoglycoside paromomycin: "Translational fidelity was impaired in the absence of functional RAC or Ssb1/2p, and the effect was further enhanced by paromomycin" (PMID: 15456889).

A mechanistic basis for this was later established: RAC/Ssb is required for the assembly of fully functional ribosomes. In its absence, "ribosome biogenesis is hampered such that core ribosomal particles are structurally altered at the decoding and peptidyl transferase centers" (PMID: 31114879). These altered ribosomes bind paromomycin with high affinity (KD = 76.6 nM), impairing stop/sense codon discrimination. Thus the fidelity defects seen upon Ssb loss are, at least in part, an indirect consequence of Ssb's role in producing correctly assembled ribosomes — linking co-translational chaperoning to the integrity of the translation apparatus itself.

5. Ssb has an extra-ribosomal signaling role bridging SNF1/AMPK–Glc7 with 14-3-3 Bmh1

A distinct, non-folding function of Ssb operates away from the ribosome in glucose signaling. Ssb bridges the SNF1 (yeast AMPK) and Glc7 (PP1 phosphatase) complexes, acting together with the 14-3-3 protein Bmh1 to promote Glc7-mediated dephosphorylation and inactivation of SNF1. "The defect in glucose-repression in the absence of Ssb is due to the ability of the chaperone to bridge between the SNF1 and Glc7 complexes" (PMID: 27001512).

This post-translational function requires a specific partnership: "Ssb performs this post-translational function in concert with the 14-3-3 protein Bmh, to which Ssb binds via its very C-terminus" (PMID: 27001512). Raising the levels of either Ssb or Bmh allowed Glc7 to dephosphorylate SNF1 even in the absence of the regulatory subunit Reg1, and suppressed transcriptional deregulation in Δreg1 cells. This identifies Ssb as a scaffolding/signaling factor in the glucose-repression pathway, with the extreme C-terminus serving as the Bmh1-binding determinant — a role mechanistically separable from its ribosome-associated folding activity.

6. Ssb inhibits de novo formation of the [PSI⁺] prion by properly folding nascent Sup35

Because Ssb folds nascent chains, it directly affects the fate of aggregation-prone proteins such as the translation-termination factor Sup35, whose amyloid conversion produces the [PSI⁺] prion. Ssb1/2p and RAC "were previously found to inhibit [PSI⁺] prion generation" (PMID: 33020283), and restoring normal Ssb levels cured most [PSI⁺] variants that had arisen in its absence. Conversely, "the loss of Ssb or disruption of RAC results in the increased formation of [PSI⁺]" (PMID: 26968706).

This bidirectional relationship — loss increases prion formation, restoration cures it — is strong evidence that Ssb's protective effect stems from its ability to correctly fold nascent Sup35 before it can nucleate amyloid. Ssb thus functions as a guardian against protein-based heritable conformational disorders, a role of considerable interest as a tractable model for human amyloid disease.

7. Ssb1/2p acts upstream of the chaperonin TRiC/CCT to fold WD40 β-propeller proteins

Ssb is not merely a general holdase — it feeds a defined subset of clients into the downstream chaperonin pathway. A specific class of WD40 β-propeller proteins interacts transiently with TRiC/CCT upon synthesis and requires it to fold, and "TRiC cooperates in the folding of these proteins with the ribosome-associated heat shock protein (Hsp)70 chaperones Ssb1/2p" (PMID: 14517260).

The selectivity of this relay is highlighted by a striking contrast: "newly synthesized actin and tubulins, the major known client proteins of TRiC, are independent of Ssb1/2p and instead use the co-chaperone GimC/prefoldin" (PMID: 14517260). Thus TRiC receives different substrate classes from different upstream chaperones — WD40 proteins via Ssb, cytoskeletal proteins via prefoldin/GimC. GimC can partially substitute for Ssb on WD40 substrates such as Cdc55p, but the combined deletion of SSB and GIM genes is lethal, indicating these upstream feeder systems provide overlapping but jointly essential functions. This finding defines a specific substrate handoff pathway and refines Ssb's substrate selectivity beyond a simple bulk role.

8. Domain architecture, catalyzed reaction, and the Sse1 nucleotide-exchange factor

UniProt P11484 defines Ssb1 as a 613-amino-acid, 66.6 kDa protein with the canonical Hsp70 two-domain architecture:

The catalyzed reaction is ATP + H₂O = ADP + phosphate + H⁺ (EC 3.6.4.10). Ssb binds close to the ribosomal tunnel exit, contacting ribosomal proteins RPL35, RPL39, RPL19 and rRNA (PubMed 27882919), and its ATP cycle is regulated by the Hsp110 nucleotide-exchange factor Sse1 (PubMed 16219770). Post-translational modifications include N-terminal acetylation (Ala2) and phosphorylation at Thr47 and Thr431. This architecture is the structural basis for the allosteric ATPase cycle in which the nucleotide state of the NBD controls the affinity of the SBD for substrate.

9. Ssb1 and Ssb2 are 99.3% identical paralogs, explaining functional redundancy

A direct pairwise comparison of the UniProt sequences of Ssb1 (P11484) and Ssb2 (P40150) — both exactly 613 residues — shows 609 of 613 positions identical (99.3% identity). Only four residues differ: E49Q, M413I, C435V, and A436S. Notably, three of the four substitutions (413, 435, 436) cluster in or near the substrate-binding domain. This near-perfect identity explains the extensive functional redundancy of the two paralogs and the practice throughout the literature of referring to them jointly as "Ssb1/2." Whether the small cluster of SBD-proximal differences confers any subtle substrate-preference distinction between the two paralogs remains an open question.

10. Sse1 (Hsp110) is the biogenesis-relevant nucleotide-exchange factor; Fes1 serves Ssa, not Ssb

Completing the ATPase cycle requires a nucleotide-exchange factor (NEF) to catalyze release of ADP. Yeast has three cytosolic Hsp70 NEF families (Sse1/Sse2–Hsp110, Fes1–HspBP1, and Snl1–Bag1), and the evidence points to Sse1 as Ssb's relevant NEF. Sse1 "participates in most Hsp70-mediated processes and is of particular importance in protein biogenesis and degradation" (PMID: 24671421) — consistent with its role in the co-translational, biogenesis-associated Ssb cycle. Crucially, the alternative NEF Fes1 is excluded: "Fes1 was found to interact in vivo preferentially with the Ssa family of cytosolic Hsp70 and not the co-translational Ssb homolog" (PMID: 24671421). This NEF specificity — Fes1 for Ssa, Sse1 for the biogenesis pathway including Ssb — assigns Sse1/Hsp110 as the nucleotide-exchange factor that resets Ssb for successive rounds of nascent-chain binding.

Mechanistic Model / Interpretation

The findings assemble into a coherent, mechanistically complete picture of Ssb1 as a ribosome-tethered Hsp70 that folds the nascent proteome co-translationally, driven by a full ATPase cycle whose every step is now assigned to a specific factor.

The co-translational Hsp70 cycle at the ribosomal exit tunnel

          Ribosome (60S subunit)
   ┌───────────────────────────────────┐
   │        exit tunnel                 │
   │            │                        │
   │            ▼  nascent chain         │
   uL23/Rpl25 ─────┤        ~~~~~~~~~~~                  │
   (docking site)  │       /           \                │
   │      │  RAC        │  ← Zuo1 (J-domain) + Ssz1
   │      │ positions & │     stimulate Ssb ATPase &
   │      │ activates   │     position SBD at tunnel
   └──────┼─────────────┼──────────────┘
          │             │
          ▼             │
    ┌───────────┐       │
    │   Ssb1    │       │
    │ NBD + SBD │       │
    └───────────┘       │
          │             │
 ATP-bound (open, low affinity) │  ← receives nascent chain
          │             │
     RAC-stimulated hydrolysis  │  (EC 3.6.4.10)
          ▼             │
 ADP-bound (closed, high affinity) — grips substrate
          │
      Sse1 (Hsp110 NEF) exchanges ADP → ATP
          │
          ▼
  release; chain folds or
  is relayed to TRiC/CCT
  (WD40 β-propeller clients)

Step by step: (1) Ssb1 docks at the ribosomal exit tunnel via uL23/Rpl25 and neighboring ribosomal proteins/rRNA (F003, F008). (2) RAC — the Zuo1–Ssz1 heterodimer — both stimulates Ssb's ATPase and positions the ATP-bound (open, low-affinity) SBD directly over the emerging chain (F002, F003). (3) A nascent-chain segment enriched in positively charged and aromatic residues enters the SBD (F001). (4) RAC-stimulated ATP hydrolysis (EC 3.6.4.10) closes the SBD lid, converting Ssb to the high-affinity ADP state that grips the substrate (F008). (5) The Hsp110 NEF Sse1 catalyzes ADP→ATP exchange, reopening the SBD and releasing the segment (F010). (6) Through multiple such bind-release cycles the chain is kept folding-competent; general clients fold locally, while specific WD40 β-propeller clients are relayed to the downstream chaperonin TRiC/CCT (F007).

This cycle is now fully populated with molecular actors: substrate specificity (degenerate basic/aromatic motif), the J-protein activator (RAC/Zuo1–Ssz1), the ribosomal docking site (uL23/Rpl25), the catalyzed reaction (ATP hydrolysis, EC 3.6.4.10), and the nucleotide-exchange factor (Sse1/Hsp110).

Two functional pools: ribosomal and extra-ribosomal

Ssb1 operates in two spatially and functionally distinct modes:

The ribosomal pool (F001–F004, F006, F007) accounts for the protein's canonical annotation as a co-translational chaperone, its role in translational fidelity/ribosome biogenesis, its suppression of the [PSI⁺] prion (by folding nascent Sup35), and its substrate handoff to TRiC. The extra-ribosomal pool (F005) reflects a genuinely distinct moonlighting function in metabolic signaling, mediated by a different part of the protein (the C-terminus) and a different set of partners.

Redundancy and evolutionary interpretation

The 99.3% identity between Ssb1 and Ssb2 (F009) indicates a recent gene duplication with essentially no functional divergence, so that the two are effectively interchangeable and studied as "Ssb1/2." This redundancy buffers the cell against loss of either single gene, and it means most published phenotypes reflect the loss of both paralogs.

Evidence Base

The report rests on a mixture of high-resolution structural, biochemical, ribosome-profiling, genetic, and bioinformatic evidence. The strongest, most precise studies are prioritized below.

Supporting/contextual literature reviewed includes studies on RAC/Ssb in translational repression of polylysine-stalled ribosomes (PMID: 23007158, PMID: 25154418), the sequential recruitment of Hsp70/Ssb before TRiC governed by nascent-chain topology and elongation rate (PMID: 31400849), cotranslational assembly of protein complexes (PMID: 30158700), cooperation of Ssb/RAC with the RQC ubiquitin ligase Ltn1 (PMID: 32957466), and multiple studies on Ssb's modulation of prions and heritable elements (PMID: 37240005, PMID: 27828954, PMID: 30995727). The kinetic advantage of tethering a chaperone at the exit tunnel — raising its effective local concentration by 4–5 orders of magnitude — is documented in PMID: 19519521.

Convergence of evidence types: The core folding function is supported by orthogonal methods — ribosome profiling (specificity), deletion proteomics (aggregation), cryo-EM (structure/positioning), crosslinking (RAC dependence), and genetics (fidelity, prions). This multi-modal convergence gives high confidence in the mechanistic model. The most recent cryo-EM work (PMID 41545346) is especially valuable because it visualizes the entire cotranslational cycle directly.

Limitations and Knowledge Gaps

1. Ssb1 vs. Ssb2 individually. Because the two paralogs are 99.3% identical and are routinely deleted together, almost all functional data pertain to "Ssb1/2" jointly. Whether Ssb1 specifically has any unique substrate preference, expression pattern, or regulation distinct from Ssb2 — potentially conferred by the four differing residues clustered near the SBD (E49Q, M413I, C435V, A436S) — has not been resolved. The gene identity of P11484 as SSB1 is secure, but paralog-specific biology is largely unaddressed.

2. NEF assignment is inferential. The assignment of Sse1/Hsp110 as Ssb's nucleotide-exchange factor rests on Sse1's general importance in protein biogenesis and the exclusion of Fes1 (which prefers Ssa). A direct, quantitative demonstration of Sse1-catalyzed nucleotide exchange specifically on ribosome-bound Ssb, with kinetics, would strengthen this conclusion.

3. Substrate scope beyond WD40 proteins. While WD40 β-propellers are a well-defined TRiC-relayed client class, the full repertoire of Ssb's obligate clients (versus proteins that merely transit Ssb en route to folding) is not comprehensively catalogued. The rules governing which nascent chains fold with Ssb alone versus which require downstream handoff remain incompletely defined.

4. Mechanism of the signaling role. The extra-ribosomal SNF1–Glc7–Bmh1 bridging function is genetically well-supported, but the structural basis of the Ssb–Bmh1 C-terminal interaction and how the same protein partitions between ribosomal and signaling pools are not established.

5. Ribosome biogenesis vs. direct fidelity effects. Ssb's contributions to translational fidelity appear partly indirect (via defective ribosome assembly). Disentangling the direct co-translational folding contribution from the ribosome-biogenesis contribution to fidelity phenotypes remains difficult.

6. Quantitative aggregation phenotype. The statement that ΔSSB causes "widespread aggregation" is qualitative in this summary; the precise fraction of the proteome affected and the client-level determinants of aggregation vulnerability warrant quantitative follow-up.

Proposed Follow-up Experiments / Actions

1. Paralog-resolved functional analysis. Construct strains expressing only Ssb1 or only Ssb2 (single-paralog complementation of a Δssb1 Δssb2 background) and perform selective ribosome profiling and aggregation proteomics to test whether the four SBD-proximal residue differences produce any measurable substrate-preference divergence.

2. Direct NEF kinetics. Reconstitute purified ribosome–Ssb complexes and measure ADP-release kinetics with and without Sse1 (and Sse2) in vitro, directly confirming Sse1/Hsp110 as the nucleotide-exchange factor for Ssb and quantifying its catalytic efficiency versus Fes1 and Snl1.

3. Comprehensive client mapping. Combine Ssb selective ribosome profiling with TRiC profiling in matched conditions to define, genome-wide, which nascent chains are Ssb-only, TRiC-only, or sequentially Ssb→TRiC, refining the substrate-handoff rules (building on PMID 31400849).

4. Structural basis of Ssb–Bmh1 signaling. Determine the structure (cryo-EM or crystallography) of the Ssb C-terminus in complex with Bmh1, and use point mutants of the extreme C-terminus to selectively ablate the signaling function while preserving folding, cleanly separating the two pools.

5. Time-resolved cryo-EM of the cycle. Extend the recent cryo-EM work (PMID 41545346) with substrate- and nucleotide-trapped states to capture the ATP→ADP→ATP transitions of ribosome-bound Ssb, visualizing the conformational trajectory of the SBD lid during a single bind-release cycle.

6. Prion-folding causality. Directly test whether Ssb's [PSI⁺]-suppressing effect requires co-translational engagement of nascent Sup35 specifically (versus post-translational action) using Sup35 variants that alter the Ssb-binding motif, tying the anti-prion function precisely to the co-translational folding mechanism.

Conclusion

Yeast Ssb1 (P11484, YDL229W) is a cytosolic, ribosome-tethered Hsp70 molecular chaperone whose primary function is ATP-driven co-translational folding of the nascent proteome. Catalyzing ATP hydrolysis (EC 3.6.4.10), it docks at the 60S ribosomal exit tunnel via uL23/Rpl25, is activated and positioned by the RAC co-chaperone (Zuo1–Ssz1), captures emerging chains at degenerate basic/aromatic motifs, is reset by the Hsp110 NEF Sse1, and relays select clients (WD40 β-propellers) to TRiC/CCT. It further safeguards translational fidelity and ribosome biogenesis, suppresses the [PSI⁺] prion by folding nascent Sup35, and moonlights off-ribosome to regulate glucose repression via the SNF1–Glc7–Bmh1 axis. It is functionally redundant with its 99.3%-identical paralog Ssb2. This yeast Hsp70 is unrelated to the human single-stranded-DNA-binding proteins of the same name.

Artifacts

• OpenScientist final report
• OpenScientist final report

Citations

1. PMID:28708998
2. PMID:23332755
3. PMID:28771464
4. PMID:11929994
5. PMID:41545346
6. PMID:15456889
7. PMID:31114879
8. PMID:27001512
9. PMID:33020283
10. PMID:26968706
11. PMID:14517260
12. PMID:24671421
13. PMID:23007158
14. PMID:25154418
15. PMID:31400849
16. PMID:30158700
17. PMID:32957466
18. PMID:37240005
19. PMID:27828954
20. PMID:30995727
21. PMID:19519521

AIGR Deep Research Report — SSB1 (P11484), Saccharomyces cerevisiae

Focus type: core_function
Seed hypothesis: "The four amino-acid differences between Ssb1 and Ssb2 confer a demonstrated paralog-specific substrate preference or cotranslational folding mechanism."

Executive Judgment

Verdict: REFUTED as stated (over-annotation of a redundant paralog pair).

The hypothesis has two clauses. The factual premise — that Ssb1 and Ssb2 differ by four amino acids — is correct (verified directly: 613 aa each, 99.35 % identical, exactly 4 substitutions). The functional claim — that these differences confer a demonstrated paralog-specific substrate preference or cotranslational folding mechanism — is not supported by any primary literature. Across foundational and contemporary studies, Ssb1 and Ssb2 are treated as a single functional entity ("Ssb", "Ssb1/2p"), are deleted together, and no study assigns a distinct substrate spectrum or folding mechanism to one paralog versus the other. Three of the four differences do lie in the substrate-binding domain (SBD), which makes a paralog-specific effect structurally conceivable, but positional plausibility is not demonstration. The word "demonstrated" is the failure point: there is no such demonstration.

Most important caveat: absence of evidence for divergence is not the same as proof of perfect functional identity; a subtle, condition-specific difference has not been rigorously excluded. But for GO curation purposes, any paralog-specific MF/BP term would be unsupported and should not be asserted.

Evidence Matrix

No competing paper asserting a demonstrated Ssb1-vs-Ssb2 functional difference was found.

GO Decision Table (grounded in current SSB1 annotations, QuickGO/P11484, verified Iteration 2)

SSB1 currently carries 39 GO annotations, none of which are paralog-specific. Representative terms and the recommended action relative to the seed hypothesis:

Key point: the IMP process terms derive from double-mutant (ssb1Δ ssb2Δ) phenotypes, i.e., they document the shared Ssb function, not a paralog-resolved one. No existing term encodes a paralog-specific activity, and none should be added.

GO Curation Implications (leads — require curator verification)

• Do NOT create or retain any paralog-specific MF/BP/CC term implying Ssb1 has a substrate preference or cotranslational mechanism distinct from Ssb2. Such a term would be an over-annotation.
• Appropriate, supported terms for SSB1 (shared with SSB2, evidence-backed):
• MF: unfolded protein binding (GO:0051082); ATP binding / ATP hydrolysis activity (Hsp70 NBD).
• BP: protein folding / 'de novo' cotranslational protein folding (GO:0051083 / GO:0140719); regulation of translation / translational fidelity context.
• CC: cytosol (GO:0005829); cytosolic ribosome / ribosome-associated (polysome association, GO:0022626-adjacent).
• Recommended action: retain the general ribosome-associated Hsp70 chaperone annotations; generalize/avoid any qualifier that ascribes a unique substrate class to Ssb1. If a paralog-specific annotation currently exists, flag it for removal or down-grading to NAS/non-core.
• Avoid "protein binding" (GO:0005515) as a final call; unfolded protein binding is the more informative supported MF.

Substitution Severity Analysis (computed, Iteration 3 — provenance: ssb1_ssb2_substitution_analysis.csv)

Physicochemical severity (Grantham distance) of the four Ssb1→Ssb2 substitutions:

Mean Grantham = 82.5. Interpretation: three of four differences are conservative/moderate — consistent with near-neutral divergence between redundant WGD paralogs. The single striking substitution is C435V, which removes the only paralog-distinguishing cysteine (a redox-active thiol) in Ssb1, located in the substrate-binding β-subdomain. This makes C435 the best candidate residue for any hypothetical functional difference (e.g., redox-sensitive substrate handling), yet it remains entirely untested — no experiment links it to a substrate preference. This nuance neither rescues the "demonstrated" claim nor is dismissible; it is a lead, not evidence.

Mechanistic Scope

• Immediate molecular function (both paralogs): an ATP-dependent Hsp70 chaperone that, in complex with the RAC co-chaperone (Zuo1/Ssz1), binds hydrophobic segments of nascent polypeptides at the ribosomal exit tunnel to promote cotranslational folding and prevent misfolding/aggregation. This is a shared activity.
• The tested increment — a paralog-specific substrate preference or a distinct folding mechanism for Ssb1 — is the piece with no direct gene-product evidence.
• Downstream/pleiotropic effects (not core function, and not paralog-specific): translational repression of poly-lysine/nonstop transcripts, premature termination, prion ([PSI+]) modulation, TORC1-linked translational control. These are collective RAC/Ssb-system phenotypes.

Conflicts and Alternatives

• Paralog confusion / carry-over is the central risk. SSB1 and SSB2 arose from the whole-genome duplication and remain ~99 % identical; databases and papers routinely collapse them to "Ssb". A curation asserting Ssb1-specific function would most likely be database carry-over / inference, not demonstrated fact.
• Alternative interpretation (best-supported): the 4 differences are evolutionarily tolerated near-neutral substitutions between redundant WGD paralogs, not adaptive functional divergence. The joint-deletion requirement for phenotypes (single deletions are near-silent) is classic redundancy.
• Residue-level nuance: C435V removes a cysteine unique to Ssb1 (potential redox/thiol difference) and M413I/A436S sit in the SBDβ — these could seed a testable hypothesis, but currently support only speculation, not a "demonstrated" claim.

Knowledge Gaps

1. Has any assay directly compared Ssb1-only vs Ssb2-only cells/proteins? Checked PubMed broadly; none found. Matters because it is the exact evidence the hypothesis claims exists. Resolve with paralog-swap strains + selective ribosome profiling (SeRP).
2. Do the 4 residues alter substrate contacts? Checked UniProt features — none are annotated substrate/nucleotide binding sites; three are merely within the SBD region. Resolve with structural modeling of the peptide-binding cleft and in vitro peptide-array affinity comparison.
3. Expression/regulatory divergence? Not resolved here; even if promoters differ, that would be regulatory, not the "substrate preference / folding mechanism" claimed. Resolve with paralog-specific expression datasets.

Discriminating Tests

• Selective ribosome profiling (SeRP) on FLAG-Ssb1-only vs FLAG-Ssb2-only strains (each in ssb1Δ ssb2Δ background) → directly tests differential nascent-chain substrate spectra.
• Reciprocal complementation: does SSB2 fully rescue ssb1Δ phenotypes and vice versa across stress panels? Full rescue = redundancy (refutes); a specific non-complemented phenotype = paralog-specific (would support).
• In vitro peptide-binding / ATPase kinetics of purified Ssb1 vs Ssb2 (and site-swap mutants at 49/413/435/436) → isolates the causal contribution of the 4 residues.
• Cys435 redox probe: test thiol-dependent behavior unique to Ssb1.

Curation Leads (verify before applying)

• Lead 1 — Reject paralog-specific functional annotation. No primary evidence supports a distinct Ssb1 substrate preference or mechanism; treat as over-annotation.
• Lead 2 — Candidate references to cite for shared function: PMID 23332755 (SSB cotranslational substrate specificity, as one entity), PMID 1394434 (Ssb1/2p ribosome association), PMID 35701497 / 37081320 (RAC–Ssb cotranslational folding mechanism).
• Snippet to verify (PMID 23332755): "we use a sensitive and global approach to define the cotranslational substrate specificity of the yeast Hsp70 SSB."
• Snippet to verify (PMID 1394434): "The SSB hsp70s (Ssb1/2p) are associated with translating ribosomes."
• Lead 3 — Suggested curator question: Is any existing Ssb1-specific term backed by an experiment using an Ssb1-only reagent/strain, or is it inferred from the shared "Ssb" literature? If the latter, generalize the term to reflect shared function.
• Lead 4 — Suggested experiment (if lab-backed curation desired): paralog-swap SeRP (see Discriminating Tests).

Confidence

High confidence that the hypothesis is not demonstrated (verdict: refuted-as-stated / over-annotation). Moderate residual uncertainty that a subtle, untested paralog difference exists — relevant only if future experiments provide it; it should not drive current curation.

Artifacts

• OpenScientist final report
• OpenScientist final report
• OpenScientist ssb1 ssb2 substitution analysis